Anti-Inflammatory Modified Fuzi Decoction Antagonizes Synovial TNF-α/TRAF2/NF-κB Signaling to Remedy Osteoarthritis.

Drug design, development and therapy2025Wang Y, Ren J, Chen H, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2025
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 4 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalArthritis, ExperimentalCells, CulturedDisease Models, AnimalDose-Response Relationship, DrugDrugs, Chinese HerbalIodoacetic AcidMaleNF-kappa BOsteoarthritisRatsRats, Sprague-DawleySignal TransductionStructure-Activity RelationshipSynovial MembraneTNF Receptor-Associated Factor 2Tandem Mass SpectrometryTumor Necrosis Factor-alpha

DOI 10.2147/dddt.s481770

PMID 40918953

View source →